Dr. Matthew Ezra Emanuel, MD

Dr. Emanuel practices at Glaucoma Associates of Texas PA in Fort Worth, Texas.

Dr. Emanuel's NPI, 1487986170, was assigned on February 4, 2010. Dr. Emanuel graduated from Vanderbilt University School Of Medicine in 2009. Dr. Emanuel holds Texas license Q0041.

Dr. Emanuel's primary practice is Glaucoma Associates of Texas PA, at 417 W Magnolia Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (214) 360-0000.

Dr. Emanuel's primary practice is Glaucoma Associates of Texas PA in Fort Worth, Texas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Emanuel to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Emanuel practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Emanuel's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Emanuel is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Emanuel's licenses on file in 3 states: Texas, Georgia and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Emanuel treats.

CMS data shows 4,855 Medicare services from Dr. Emanuel across 21 procedure codes in 2024, for 944 Medicare patients. Medicare paid $318,848 for them.

CMS counts 944 Medicare patients who saw Dr. Emanuel in 2024. The largest group is 75 to 84, with 389 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Emanuel's median patient age at 72, with 53% women.

In 2024, Dr. Emanuel wrote 7,341 Medicare Part D claims for 1,468 patients. 65% of them were for generic drugs. CMS names the drug for 7,240 of them, across 27 drugs with 11 or more claims each, at $494,679 in total drug cost. In 2023, CMS named 6,844 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Emanuel for performance year 2024, reported as part of a group. Dr. Emanuel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 114 procedures of cataract surgery by Dr. Emanuel, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Emanuel, published from 2010 to 2019. The most frequent topics are Intraocular Pressure, Tonometry, Ocular and Disease Progression. Dr. Emanuel has published most often in J Glaucoma. Dr. Emanuel's most frequent co-authors are Ronald Leigh Fellman, MD, David Gray Godfrey, MD and Davinder S. Grover, MD, MPH.

CMS Open Payments shows 287 general payments to Dr. Emanuel from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Aerie Pharmaceuticals, Inc. paid the most, $66,370.

Dr. Emanuel graduated from Vanderbilt University School Of Medicine in 2009.

Dr. Emanuel is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.